The Journal of Clinical Psychiatry

Letter to the Editor November 1, 2002

High Degree of Tolerability for Monotherapy With High Doses of Quetiapine: A Case Report

; ; ; ; ;

J Clin Psychiatry 2002;63(11):1048-1049

Article Abstract

Letter to the Editor

Sir: Quetiapine is a relatively new third-generation antipsychotic with a labeled dose range of 400 to 800 mg/day. Quetiapine has demonstrated efficacy in the management of patients with a history of partial response to conventional antipsychotics. We report the case of a schizophrenic woman who achieved full clinical remission without significant side effects with a high dose of quetiapine (1600 mg/day). To our knowledge, evidence from daily clinical practice or controlled clinical trials has never been published on high doses of this new antipsychotic.

From the Editors

 

This PDF is free for all visitors!